# HEXCEL CORP /DE/ (HXL) FY 2024 MD&A

Verbatim Item 7 Management's Discussion and Analysis from HEXCEL CORP /DE/'s 10-K for fiscal year 2024.

SEC filing source: https://www.sec.gov/Archives/edgar/data/717605/000095017025014412/hxl-20241231.htm
Accession: 0000950170-25-014412
Filing date: 2025-02-05
Report date: 2024-12-31
Extracted from a later financial-section MD&A body after the formal Item 7 span was a short reference.
Confidence: high

Company profile: /company/HXL/
All MD&A years: /company/HXL/mda/
Previous year: /company/HXL/mda/fy2023/ (FY 2023)
Next year: /company/HXL/mda/fy2025/ (FY 2025)

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s discussion and analysis of the Company’s financial condition and results of operations for the year ended December 31, 2024, and comparison to the year ended December 31, 2023 should be read in conjunction with the consolidated financial statements and notes of this Annual Report on Form 10-K.

For discussion and analysis of financial condition and results of operations for 2023 compared to 2022 refer to Part II, Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations in our 2023 Annual Report on Form 10-K, filed with the SEC on February 7, 2024, which is incorporated by reference into this Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Business Overview

[[GREPCENT_TABLE]]
[["","","For the Years Ended December 31,"],["(In millions)","","2024","","","2023"],["Net sales","","$","1,903.0","","","$","1,789.0"],["Gross margin %","","","24.7","%","","","24.2","%"],["Other operating expense","","$","50.0","","","$","1.4"],["Operating income","","$","186.1","","","$","215.3"],["Operating income %","","","9.8","%","","","12.0","%"],["Interest expense, net","","$","31.2","","","$","34.0"],["Income tax expense","","$","22.8","","","$","12.1"],["Equity in earnings from affiliated companies","","$","\u2014","","","$","8.1"],["Net income","","$","132.1","","","$","105.7"]]
[[/GREPCENT_TABLE]]

Business Trends

Since 2022, the Commercial Aerospace market and our business has seen signs of recovery from the economic impacts of the COVID-19 pandemic that began in 2020, driven by growth in air travel and an increase in aircraft build rates. However, the post-recovery period, however, continues to have many challenges across the markets Hexcel operates in, including delays in aircraft production rates, related to, among other impacts, global logistics, supply chain issues, inflationary pressures, and effects from geopolitical issues and conflicts. These challenges have had and may continue to have further negative impacts on our operations, supply chain, transportation networks and customers, all of which have and may continue to compress our financial results.

In 2024, our Commercial Aerospace sales increased 11.8% compared to 2023. The 2024 increase in sales was primarily driven by growth in wide-bodies. Other Commercial Aerospace, which includes business jets and regional aircraft saw an increase in sales as well, driven by growth in regional jets. The demand for new commercial aircraft continues to be principally driven by airline passenger traffic (measured by revenue passenger miles) and the replacement rate for existing aircraft. The Commercial Aerospace industry continues to utilize a greater proportion of advanced composite materials with each new generation of aircraft.

Space & Defense sales in 2024 increased 4.5% compared to 2024. Growth was led by military helicopters including the CH-53-K, as well as the F-35, partially offset by significantly lower Bell Boeing V-22 sales.

Industrial sales decreased 20.9% in 2024. Industrial sales include automotive, recreation, wind energy and general industrial applications. The lower sales in 2024 were due to declines in all sub-markets.

Results of Operations

We have two reportable segments: Composite Materials and Engineered Products. Although these segments provide customers with different products and services, they often overlap within our three end business markets: Commercial Aerospace, Space & Defense and Industrial. Therefore, we also find it meaningful to evaluate the sales of our segments through these business markets. Further discussion and additional financial information about our segments may be found in Note 18 to the accompanying consolidated financial statements of this Annual Report on Form 10-K.

Net Sales: Consolidated net sales of $1,903.0 million for 2024 increased by 6.4% (6.4% in constant currency) compared to 2023. The sales increase in 2024 reflects higher Commercial Aerospace and Space & Defense sales, partially offset by a decline in Industrial sales.

The following table summarizes net sales to third-party customers by segment and end market in 2024 and 2023:

32

[[GREPCENT_TABLE]]
[["(In millions)","","Commercial Aerospace","","","Space & Defense","","","Industrial","","","Total"],["2024 Net Sales"],["Composite Materials","","$","1,008.2","","","$","386.8","","","$","136.0","","","$","1,531.0"],["Engineered Products","","","186.0","","","","182.7","","","","3.3","","","","372.0"],["Total","","$","1,194.2","","","$","569.5","","","$","139.3","","","$","1,903.0"],["","","","63","%","","","30","%","","","7","%","","","100","%"],["2023 Net Sales"],["Composite Materials","","$","912.6","","","$","389.2","","","$","172.4","","","$","1,474.2"],["Engineered Products","","","155.6","","","","155.6","","","","3.6","","","","314.8"],["Total","","$","1,068.2","","","$","544.8","","","$","176.0","","","$","1,789.0"],["","","","60","%","","","30","%","","","10","%","","","100","%"]]
[[/GREPCENT_TABLE]]

Sales by Segment

Composite Materials: Net sales of $1,531.0 million for 2024 increased 3.9% from 2023. Commercial Aerospace sales increased 10.5% in 2024 as compared to 2023 primarily driven by growth in the Airbus A350 and Boeing 787 programs as well as regional jet growth. Space & Defense sales were relatively flat. Industrial sales in 2024 decreased 21.1% from 2023 due to the decline in all industrial sub-markets.

Engineered Products: Net sales of $372.0 million for 2024 increased 18.2% from 2023, driven by a 19.5% increase in Commercial Aerospace sales. Space & Defense sales of $182.7 million increased by 17.4% from 2023, while Industrial sales in 2024 were $0.3 million lower than 2023.

Sales by Market

Commercial Aerospace: Net sales of $1,194.2 million increased 11.8% (11.9% in constant currency) for the year ended December 31, 2024 as compared to the year ended December 31, 2023. Widebodies led the growth including the Boeing 787 and Airbus A350, followed by the Airbus A320neo. Sales for the Boeing 737 MAX were down year-over-year. Other Commercial Aerospace increased reflecting growth in regional jets.

Space & Defense: Net sales of $569.5 million increased 4.5% (4.6% in constant currency) for 2024 as compared to 2023. Growth was driven by military helicopters including the CH-53-K, as well as the F-35, partially offset by declining sales for the Bell Boeing V-22.

Industrial: Net sales of $139.3 million in the full year of 2024 decreased 20.9% (21.1% in constant currency) compared to 2023 as all industrial sub-markets declined..

2024 Consolidated Results Compared to 2023

Gross Margin: Gross margin for 2024 was $469.8 million or 24.7% of net sales as compared to $433.2 million or 24.2% of net sales in 2023. The improvement in 2024 was due to the higher sales volume leverage.

Selling, General and Administrative (“SG&A”) Expenses: SG&A expenses for 2024 were $176.6 million or 9.3% of net sales as compared to $163.8 million or 9.2% of net sales for 2023. The increase in SG&A expenses in 2024 compared to 2023 was primarily due to higher employee-related costs.

Research and Technology (“R&T”) Expenses: R&T expenses for 2024 were $57.1 million or 3.0% of net sales and in 2023 were $52.7 million or 2.9% of net sales. The year-over-year increase in expenses was attributable to employee-related costs and development projects expense.

Other operating expense: Other operating expense for 2024 of $50.0 million included $46.3 million of asset impairments and $1.4 million of other charges primarily associated with the announced potential divestiture of the Neumarkt, Austria plant as well as $2.3 million of restructuring costs. Other operating expense for 2023 of $1.4 million included restructuring costs as well as the net gain of $0.8 million from the sale of the Windsor, Colorado facility.

33

Operating income: Operating income for 2024 was $186.1 million compared with operating income in 2023 of $215.3 million. Operating income as a percent of sales was 9.8% and 12.0% in 2024 and 2023, respectively. The decrease in operating income in 2024 compared to 2023 was driven by above mentioned charges in Other operating expense, partially offset by the higher sales and improved margin.

Depreciation and amortization expense of $124.0 million for 2024 decreased $0.8 million from 2023.

Other expense: We did not incur other non-operating expense in 2024. Other expense for 2023 included a non-cash charge of $70.5 million related to the completion of the buy-out of the UK pension plan and a gain of $1.9 million related to excess assets from the UK pension plan that reverted back to the Company. Amounts for 2023 also included a charge of $3.0 million on the sale of our 50% interest in the joint venture in Malaysia.

Interest expense: Interest expense was $31.2 million for 2024 and $34.0 million for 2023 with the decrease due to lower average debt levels, partially offset by higher interest rates.

Income tax expense: For the years ended December 31, 2024 and 2023, we had a tax provision of $22.8 million and $12.1 million, respectively.

Equity in earnings from affiliated companies: Earnings represent our portion of the earnings or losses from our joint venture in Malaysia. In December 2023, we sold our 50% interest in the joint venture and received net proceeds of $44.7 million.

Net income: Net income was $132.1 million or $1.59 per diluted share for the year ended December 31, 2024 compared to net income of $105.7 million or $1.24 per diluted share for the year ended December 31, 2023. The increase in 2024 was driven by higher sales as well as the impacts of the items discussed above.

Financial Condition

In 2024, we ended the year with total debt, net of cash, of $575.3 million and generated $289.9 million of operating cash resulting in $202.9 million of free cash flow (cash provided by operating activities less cash paid for capital expenditures). We expect our cash flow needs for fiscal year 2025 will be funded by cash generated from our operations as well as available borrowings under our Senior Unsecured Revolving Credit Facility (the “Facility”) as needed.

We have a portfolio of derivatives related to currencies, interest rates and commodities. We monitor our counterparties, and we only use those rated investment grade.

Liquidity

Our cash on hand at December 31, 2024 was $125.4 million, as compared to $227.0 million at December 31, 2023. Of the total cash on hand at December 31, 2024, $46.8 million was held by our foreign locations. As of December 31, 2024 total debt was $700.7 million, as compared to $699.5 million at December 31, 2023. As of December 31, 2024, we were in compliance with all debt covenants.

On April 25, 2023, we entered into a new credit agreement (the “Credit Agreement”) to refinance the “Facility". Under the terms of the Credit Agreement the borrowing capacity is $750 million. The Facility matures in April 2028.

As of December 31, 2024, there were no outstanding borrowings under the Facility. The Credit Agreement permits us to issue letters of credit up to an aggregate amount of $50 million. Outstanding letters of credit reduce the amount available for borrowing under the Facility. As of December 31, 2024, there were no issued letters of credit under the Facility, resulting in undrawn availability under the Facility of $750 million.

For more information regarding the Facility, see Note 6, Debt, to the accompanying consolidated financial statements of this Annual Report on Form 10-K.

Short-term liquidity requirements consist primarily of normal recurring operating expenses and working capital needs, capital expenditures, dividend payments, debt obligations and debt service requirements. We expect to meet our short-term liquidity requirements through net cash from operating activities, cash on hand and the Facility. As of December 31, 2024, long-term liquidity requirements consist primarily of obligations under our long-term debt obligations. We do not have any significant required debt repayments until August 2025 when our 4.7% Senior Unsecured Notes are due.

34

The remaining authorization under the share repurchase program at December 31, 2024 was $234.9 million. On January 21, 2025, our Board of Directors declared a quarterly dividend of $0.17 per share payable to stockholders of record as of February 7, 2025, with a payment date of February 14, 2025.

Operating Activities: We generated $289.9 million in cash from operating activities during 2024, an increase of $32.8 million from 2023. The increase in the current year was due to higher net income and lower use of working capital. Lower working capital for the year ended December 31, 2024 was primarily due to lower accounts receivable and higher accruals, partially offset by higher inventories.

Investing Activities: Net cash used for investing activities was $87.0 million in 2024 compared to $50.7 million in 2023. Capital expenditures for 2024 were $87.0 million compared to $108.2 million in 2023, which included $38.0 million for the acquisition of the land and building at our Amesbury, Massachusetts facility. 2023 also included net proceeds of $44.7 million from the sale of our 50% interest in the joint venture in Malaysia and $10.3 million from the sale of the Windsor, Colorado facility.

Financing Activities: Net cash used for financing activities was $301.7 million in 2024 as compared to $92.6 million in 2023. Borrowings and repayments under the Facility during 2024 were both $160 million. In 2023, borrowings were $103 million, while repayments were $128 million. Dividend payments to shareholders were $49.3 million and $42.2 million in the years ended December 31, 2024 and 2023, respectively. Repurchases of common stock totaled $252.2 million and $30.1 million in the years ended December 31, 2024 and 2023, respectively.

Financial Obligations and Commitments: We had $0.1 million of current debt maturities as of December 31, 2024. The next significant scheduled debt maturity will not occur until August 2025 when our 4.7% Senior Unsecured Notes are due. In addition, certain sales and administrative offices, data processing equipment, vehicles and manufacturing equipment, land and facilities are leased under operating leases.

The following table summarizes the scheduled maturities as of December 31, 2024 of financial obligations and expiration dates of commitments for the years ended 2025 through 2029 and thereafter.

[[GREPCENT_TABLE]]
[["(In millions)","","2025","","","2026","","","2027","","","2028","","","2029","","","Thereafter","","","Total"],["Senior unsecured credit facility due 2028","","$","","","","","","","","","","","","","","","","","","","","","","","","$","","\u2014"],["4.7% senior notes due 2025","","","","300.0","","","","","\u2014","","","","","\u2014","","","","","\u2014","","","","","\u2014","","","","","\u2014","","","","","300.0"],["3.95% senior notes due 2027","","","","\u2014","","","","","\u2014","","","","","400.0","","","","","\u2014","","","","","\u2014","","","","","\u2014","","","","","400.0"],["Purchase obligations","","","","15.1","","","","","11.2","","","","","8.9","","","","","6.2","","","","","5.5","","","","","42.0","","","","","88.9"],["Finance lease and other","","","","0.1","","","","","\u2014","","","","","\u2014","","","","","\u2014","","","","","\u2014","","","","","\u2014","","","","","0.1"],["Subtotal","","$","","315.2","","","$","","11.2","","","$","","408.9","","","$","","6.2","","","$","","5.5","","","$","","42.0","","","$","","789.0"],["Operating leases","","","","6.7","","","","","6.0","","","","","5.0","","","","","4.2","","","","","2.5","","","","","3.9","","","","","28.3"],["Total financial obligations","","$","","321.9","","","$","","17.2","","","$","","413.9","","","$","","10.4","","","$","","8.0","","","$","","45.9","","","$","","817.3"],["Interest payments","","","","27.3","","","","","17.9","","","","","3.2","","","","","0.4","","","","","\u2014","","","","","\u2014","","","","","48.8"],["Estimated benefit plan contributions","","","","18.0","","","","","2.2","","","","","2.3","","","","","2.4","","","","","1.5","","","","","9.0","","","","","35.4"],["Total commitments","","$","","367.2","","","$","","37.3","","","$","","419.4","","","$","","13.2","","","$","","9.5","","","$","","54.9","","","$","","901.5"]]
[[/GREPCENT_TABLE]]

As of December 31, 2024, we had $2.8 million of unrecognized tax benefits. This represents tax benefits associated with various tax positions taken, or expected to be taken, on domestic tax returns that have not been recognized in our financial statements due to uncertainty regarding their resolution. The resolution or settlement of these tax positions with the taxing authorities is at various stages.

For further information regarding our financial obligations and commitments, see Notes 6, 7, 8 and 16 to the accompanying consolidated financial statements of this Annual Report on Form 10-K.

Non-GAAP Financial Measures

The Company uses non-GAAP financial measures, including sales and expenses measured in constant dollars (prior year sales and expenses measured at current year exchange rates); operating income, net income and diluted earnings per share adjusted for items included in operating expense and non-operating expenses; and free cash flow. Management believes these non-GAAP measures are meaningful to investors because they provide a view of Hexcel with respect to ongoing operating results and comparisons to prior periods. These adjustments can represent significant charges or credits that we believe are important to an understanding of Hexcel’s overall operating results in the periods presented. Such non-GAAP measures are not determined in accordance with generally accepted

35

accounting principles and should not be viewed in isolation or as an alternative to or substitutes for GAAP measures of performance. Our calculation of these measures may not be comparable to similarly titled measures used by other companies, and the measures exclude financial information that some may consider important in evaluating our performance. Reconciliations to adjusted operating income, adjusted net income, adjusted diluted net income per share and free cash flow are provided below.

[[GREPCENT_TABLE]]
[["","","Year Ended December 31,"],["(In millions)","","2024","","","2023"],["GAAP operating income","","$","186.1","","","$","215.3"],["Other operating expense (1)","","","50.0","","","","1.4"],["Adjusted operating income (Non-GAAP)","","$","236.1","","","$","216.7"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["","","Year Ended December 31,"],["","","2024","","2023"],["(In millions, except per diluted share data)","","Net Income","","","EPS","","","","Net Income","","","EPS"],["GAAP net income","","$","132.1","","","$","1.59","","","","$","105.7","","","$","1.24"],["Other operating expense, net of tax (1)","","","40.5","","","","0.49","","","","","1.0","","","","0.01"],["Other expense, net of tax (2)","","","\u2014","","","","\u2014","","","","","57.4","","","","0.67"],["Tax benefit (3)","","","(4.1",")","","","(0.05",")","","","","(9.3",")","","","(0.11",")"],["Adjusted net income (Non-GAAP)","","$","168.5","","","$","2.03","","","","$","154.8","","","$","1.81"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["","","Year Ended December 31,"],["(In millions)","","2024","","","2023"],["Net cash provided by operating activities","","$","289.9","","","$","257.1"],["Less: Capital expenditures","","","(87.0",")","","","(108.2",")"],["Free cash flow (Non-GAAP)","","$","202.9","","","$","148.9"]]
[[/GREPCENT_TABLE]]

(1)
The year ended December 31, 2024 included asset impairments and other charges primarily associated with the announced potential divestiture for our Neumarkt, Austria plant. The year ended December 31, 2024 also included restructuring costs. The year ended December 31, 2023 included the net gain of $0.8 million from the sale of the Windsor, Colorado facility and restructuring costs.

(2)
The year ended December 31, 2023 included a non-cash settlement charge of $70.5 million related to the completion of the buy-out of the UK pension plan and a gain of $1.9 million related to excess assets from the UK pension plan that reverted back to the Company. 2023 also included a charge of $3.0 million on the sale of our 50% interest in the joint venture in Malaysia.

(3)
The year ended December 31, 2024 included benefits associated with our R&D expenditures, partially offset by the recording of a valuation allowance in a foreign jurisdiction. The year ended December 31, 2024 also included a discrete tax benefit related to adjustments to our provision based on the finalization of prior year tax returns. The year ended December 31, 2023 included a discrete tax benefit primarily related to adjustments to our provision based on the finalization of prior year tax returns.

Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared based upon the selection and application of accounting principles generally accepted in the United States of America, which require us to make estimates and assumptions about future events that affect amounts reported in our financial statements and accompanying notes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment. Actual results could differ from those estimates, and any such differences may be significant to the financial statements. The accounting policies below are those we believe are the most critical to the preparation of our financial statements and require the most difficult, subjective, and complex judgments. Our other accounting policies are described in the accompanying Notes to the consolidated financial statements of this Annual Report on Form 10-K.

Income Taxes

We have operations in several countries throughout the world where we are subject to income and similar taxes. The estimation of income tax amounts often involves the interpretation of complex regulations and tax laws. In addition, estimations also must consider the impact foreign taxes may have on domestic taxes, as well as the analysis of the realizability of deferred tax assets, tax audit

36

findings and uncertain tax positions. Although we believe our tax accruals are adequate, differences may occur in the future, depending on the resolution of pending and new tax matters.

Deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is provided against a deferred tax asset when it is more likely than not that all or some portion of the deferred tax asset will not be realized. The determination of the required valuation allowance and the amount, if any, of deferred tax assets to be recognized involves significant estimates regarding the timing and amount of reversal of taxable temporary differences, future taxable income, and the implementation of tax planning strategies. In particular, ASC 740, Income Taxes, requires that all available positive and negative evidence be weighed to determine whether a valuation allowance should be recorded.

We are subject to taxation in the U.S. and various states and foreign jurisdictions. The amount of income taxes we pay are subject to ongoing audits by federal, state and foreign tax authorities, which may result in proposed assessments. Our estimate for the potential outcome for any uncertain tax issue is judgmental. We assess our income tax positions, and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. We recognize interest accrued related to unrecognized tax benefits as a component of interest expense and penalties as a component of income tax expense in the consolidated statements of operations. If we do not believe that it is more likely than not that a tax benefit will be sustained, no tax benefit is recognized. As of December 31, 2024, we had uncertain tax positions for which it is reasonably possible that amounts of unrecognized tax benefits could significantly change over the next year. These uncertain tax positions relate to our tax returns from 2014 onward.

For further discussion, see Note 9, Income taxes, to the accompanying consolidated financial statements of this Annual Report on Form 10-K.

Retirement and Other Postretirement Benefit Plans

We maintain qualified defined benefit retirement plans covering certain current and former European employees, as well as nonqualified defined benefit retirement plans, and retirement savings plans covering certain eligible U.S. and European employees and participate in a union sponsored multi-employer pension plan covering certain U.S. employees with union affiliations. In addition, we provide certain postretirement health care and life insurance benefits to eligible U.S. retirees. We have defined benefit retirement plans in Belgium, France, and Austria covering certain employees of our subsidiaries in those countries. During the fourth quarter of 2023, we finalized the buy-out of the UK plan and we no longer have any obligations relative to the plan.

Under the retirement savings plans, eligible U.S. employees can contribute up to 75% of their compensation to an individual 401(k) retirement savings account. We make matching contributions equal to 50% of employee contributions, not to exceed 3% of employee compensation.

We use actuarial models to account for our pension and postretirement plans, which require the use of certain assumptions, such as the expected long-term rate of return, discount rate, rate of compensation increase, healthcare cost trend rates, and retirement and mortality rates, to determine the net periodic costs of such plans. These assumptions are reviewed and set annually at the beginning of each year. In addition, these models use an “attribution approach” that generally spreads individual events, such as plan amendments and changes in actuarial assumptions, over the service lives of the employees in the plan.

We use our actual return experience, future expectations of long-term investment returns, and our actual and targeted asset allocations to develop our expected rate of return assumptions used in the net periodic cost calculations of our funded European defined benefit retirement plans. Due to the difficulty involved in predicting the market performance of certain assets, there will almost always be a difference in any given year between our expected return on plan assets and the actual return. Following the attribution approach, each year’s difference is amortized over a number of future years. Over time, the expected long-term returns are designed to approximate the actual long-term returns and therefore result in a pattern of income and expense recognition that more closely matches the pattern of the services provided by the employees.

We annually set our discount rate assumption for retirement-related benefits accounting to reflect the rates available on high-quality, fixed-income debt instruments. The rate of compensation increase, which is another significant assumption used in the actuarial model for pension accounting, is determined by us based upon our long-term plans for such increases and assumed inflation. For the postretirement health care and life insurance benefits plan, we review external data and its historical trends for health care costs to determine the health care cost trend rates. Retirement and mortality rates are based primarily on actual plan experience.

Actual results that differ from our assumptions are accumulated and amortized over future periods and therefore, generally affect the net periodic costs and recorded obligations in such future periods. While we believe that the assumptions used are appropriate, significant changes in economic or other conditions, employee demographics, retirement and mortality rates, and investment performance may materially impact such costs and obligations.

37

For more information regarding our pension and other postretirement benefit plans, see Note 8, Retirement and Other Postretirement Benefit Plans, to the accompanying consolidated financial statements of this Annual Report on Form 10-K.

Long-Lived Assets and Goodwill

We have significant long-lived assets. We review these assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The assessment of possible impairment is based upon our ability to recover the carrying value of the assets from the estimated undiscounted future net cash flows, before interest and taxes, of the related operations. If these cash flows are less than the carrying value of such assets, an impairment loss is recognized for the difference between estimated fair value and carrying value. The measurement of impairment requires estimates of these cash flows and fair value. The calculation of fair value is determined based on discounted cash flows. In determining fair value, a considerable amount of judgment is required to determine discount rates, market premiums, financial forecasts, and asset lives.

In addition, we review goodwill for impairment at the reporting unit level at least annually, and whenever events or changes in circumstances indicate that goodwill might be impaired. We have four reporting units within the Composite Materials segment, each of which are components that constitute a business for which discrete financial information is available and for which appropriate management regularly reviews the operating results. Within the Engineered Products segment, the reporting unit is the segment as it comprises only a single component.

Commitments and Contingencies

We are involved in litigation, investigations and claims arising out of the normal conduct of our business, including those relating to commercial transactions, environmental, employment and health and safety matters. We estimate and accrue our liabilities resulting from such matters based upon a variety of factors, including the stage of the proceeding; potential settlement value; assessments by internal and external counsel; and assessments by environmental engineers and consultants of potential environmental liabilities and remediation costs. We believe we have adequately accrued for these potential liabilities; however, facts and circumstances may change, such as new developments, or a change in approach, including a change in settlement strategy or in an environmental remediation plan, or in our existing insurance coverage, that could cause the actual liability to exceed the estimates, or may require adjustments to the recorded liability balances in the future. For further discussion, see Note 16, Commitments and Contingencies, to the accompanying consolidated financial statements of this Annual Report on Form 10-K.

Market Risks

As a result of our global operating and financing activities, we are exposed to various market risks that may affect our consolidated results of operations and financial position. These market risks include, but are not limited to, fluctuations in currency exchange rates, which impact the U.S. dollar value of transactions, assets and liabilities denominated in foreign currencies and fluctuations in interest rates, which impact the amount of interest we must pay on certain debt instruments. Our primary currency exposures are in Europe, where we have significant business activities. To a lesser extent, we are also exposed to fluctuations in the prices of certain commodities, such as electricity, natural gas, acrylonitrile, aluminum, and certain chemicals. In addition, we have several contracts with both suppliers and customers that contain pricing adjustments based on the price of oil outside of a specified band.

We attempt to net individual exposures, when feasible, taking advantage of natural offsets. In addition, we employ or may employ interest rate, commodity and foreign currency financial instruments for the purpose of hedging certain specifically identified interest rate, commodity, and currency exposures. The use of these financial instruments is intended to mitigate some of the risks associated with fluctuations in interest rates, commodities and currency exchange rates but does not eliminate such risks. We do not use financial instruments for trading or speculative purposes.

Interest Rate Risks

Outstanding balances that exist under our Facility are included in our long-term debt bears interest at variable rates. From time to time we have entered into interest rate swap agreements to change the underlying mix of variable and fixed interest rate debt. These interest rate swap agreements have modified the percentage of total debt that is exposed to changes in market interest rates. Assuming a 10% favorable and a 10% unfavorable change in the underlying weighted average interest rates of our variable rate debt and swap agreements, interest expense for 2024 of $31.2 million would not be materially impacted.

Foreign Currency Exchange Risks

We operated twelve manufacturing facilities in Europe, Asia and Africa which generated approximately 50% of our 2024 consolidated net sales. Our European business activities primarily involve three major currencies — the U.S. dollar, the British pound

38

sterling, and the Euro. We also conduct business and sell products to customers throughout the world. Most of the sales in these countries are denominated in U.S. dollars and they have local currency expenses. Currency risk for the Asia and Africa locations is not considered material.

In 2024, our European subsidiaries had third-party sales of $0.9 billion of which approximately 68% were denominated in U.S. dollars, 31% were denominated in Euros and 1% were denominated in British pounds sterling. While we seek to reduce the exposure of our European subsidiaries to their sales in non-functional currencies through the purchase of raw materials in the same currency as that of the product sale, the net contribution of these sales to cover the costs of the subsidiary in its functional currency will vary with changes in foreign exchange rates, and as a result, so will vary the European subsidiaries’ percentage margins and profitability. For revenues denominated in the functional currency of the subsidiary, changes in foreign currency exchange rates increase or decrease the value of these revenues in U.S. dollars, but do not affect the profitability of the subsidiary in its functional currency. The value of our investments in these countries could be impacted by changes in currency exchange rates over time and could impact our ability to profitably compete in international markets.

We attempt to net individual functional currency positions of our various European subsidiaries, to take advantage of natural offsets and reduce the need to employ foreign currency forward exchange contracts. We attempt to hedge some, but not necessarily all, of the net exposures of our European subsidiaries resulting from sales they make in non-functional currencies. The benefit of such hedges varies with time and the foreign exchange rates at which the hedges are set. For example, when the Euro strengthened against the U.S. dollar, the benefit of new hedges placed was much less than the value of hedges they replaced that were entered into when the U.S. dollar was stronger. We may place additional foreign currency hedges when the dollar strengthens against the Euro or British pound. We do not seek to hedge the value of our European subsidiaries’ functional currency sales and profitability in U.S. dollars. We also enter into short-term foreign currency forward exchange contracts, usually with a term of ninety days or less, to hedge net currency exposures. Any unrealized gain or loss on these foreign currency forward exchange contracts would be offset by corresponding decreases or increases, respectively, of the underlying transaction being hedged.

We have performed a sensitivity analysis as of December 31, 2024 using a modeling technique that measures the changes in the fair values arising from a hypothetical 10% adverse movement in the levels of foreign currency exchange rates relative to the U.S. dollar with all other variables held constant. The analysis includes all of our foreign currency hedge contracts. The sensitivity analysis indicated that a hypothetical 10% adverse movement in foreign currency exchange rates would have an approximately $2.7 million impact on our 2024 operating income. However, it should be noted that over time as the adverse movement (in our case a weaker dollar as compared to the Euro or the British pound sterling) continues and new hedges are layered in at the adverse rate, the impact would be more significant. For example, had we not had any hedges in place for 2024, a 10% adverse movement would have reduced our operating income by approximately $28.9 million.

Foreign Currency Forward Exchange Contracts

A number of our European subsidiaries are exposed to the impact of exchange rate volatility between the U.S. dollar and the subsidiaries’ functional currencies, being either the Euro or the British pound sterling. We entered into contracts to exchange U.S. dollars for Euros and British pound sterling through June 2027. The aggregate notional amount of these contracts was $386.4 million at December 31, 2024. The purpose of these contracts is to hedge a portion of the forecasted transactions of European subsidiaries under long-term sales contracts with certain customers. These contracts are expected to provide us with a more balanced matching of future cash receipts and expenditures by currency, thereby reducing our exposure to fluctuations in currency exchange rates. For the three years ended December 31, 2024, hedge ineffectiveness was immaterial. Cash flows associated with these contracts are classified within net cash provided by operating activities of continuing operations.

For further discussion, see Note 15, Derivative Financial Instruments, to the accompanying consolidated financial statements of this Annual Report on Form 10-K.

39

Consolidated Financial Statements and Supplementary Data

[[GREPCENT_TABLE]]
[["Description","","Page"],["Management\u2019s Responsibility for Consolidated Financial Statements","","41"],["Management\u2019s Report on Internal Control Over Financial Reporting","","41"],["Reports of Independent Registered Public Accounting Firm","","42"],["Consolidated Financial Statements of Hexcel Corporation and Subsidiaries:"],["Consolidated Balance Sheets as of December 31, 2024 and 2023","","45"],["Consolidated Statements of Operations for each of the three years ended December 31, 2024, 2023 and 2022","","46"],["Consolidated Statements of Comprehensive Income (Loss) for each of the three years ended December 31, 2024, 2023 and 2022","","46"],["Consolidated Statements of Stockholders\u2019 Equity for each of the three years ended December 31, 2024, 2023 and 2022","","47"],["Consolidated Statements of Cash Flows for each of the three years ended December 31, 2024, 2023, and 2022","","48"],["Notes to the Consolidated Financial Statements","","49"]]
[[/GREPCENT_TABLE]]

40